Swayam Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.07 Cr
- Satisfied Charges ₹ 2.31 Cr
- Revenue Growth 12.10%
- Profit Growth 15.69%
- Ebitda -1.25%
- Net Worth 17.45%
- Total Assets 35.21%
About Swayam Biotech
Swayam Biotech Private Limited (SBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 June 2005 and has a history of 19 years and seven months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹3.07 Cr. The company has closed loans amounting to ₹2.31 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amit Kashikar and Sandeep Saraf serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24120MH2005PTC154366
-
Company No.
154366
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Jun 2005
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Swayam Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Kashikar
|
Managing Director | 30-Jun-2005 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sandeep Saraf
|
Director | 30-Aug-2013 | Current |
Financial Performance of Swayam Biotech.
Swayam Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.1% increase. The company also saw a substantial improvement in profitability, with a 15.69% increase in profit. The company's net worth Soared by an impressive increase of 17.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swayam Biotech?
In 2022, Swayam Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Agpro Biotech Private LimitedAmit Kashikar is a mutual person
Charges (Loans)
₹30.70 M
₹23.06 M
Charges Breakdown by Lending Institutions
- Others : 3.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Aug 2023 | Others | ₹2.38 M | Open |
| 01 Aug 2023 | Others | ₹2.76 Cr | Open |
| 19 Dec 2022 | Others | ₹0.70 M | Open |
| 30 Apr 2010 | Others | ₹2.11 Cr | Satisfied |
| 05 May 2008 | Punjab National Bank | ₹2.00 M | Satisfied |
How Many Employees Work at Swayam Biotech?
Swayam Biotech has a workforce of 7 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swayam Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swayam Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
